Skip to content

Haemonetics HAE Other Financing

Other Financing at other companies

TFX
TeleflexTFX
$58K+3.6%
Medtronic logo
MedtronicMDT
$70M+567%
LivaNova logo
LivaNovaLIVN
$1.69M+3,780%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.14M+4,019%
Danaher logo
DanaherDHR
-$28M-233%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
-$2M+66.7%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's other financing?
Haemonetics (HAE) reported other financing of -$13K in Q1 2026.
How has Haemonetics's other financing changed year-over-year?
Haemonetics's other financing increased by 51.9% year-over-year, from -$27K to -$13K.
What is the long-term trend for Haemonetics's other financing?
Over 3 years (2022 to 2026), Haemonetics's other financing has grown at a -72.3% compound annual growth rate (CAGR), from $4.79M to -$102K.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.